Context Therapeutics logo

Context Therapeutics Share Price Today

(NASDAQ: CNTX)

Context Therapeutics share price is $0.84 & ₹73.05 as on 6 Mar 2025, 2.30 'hrs' IST

$0.84

Market is closed - opens 8 PM, 06 Mar 2025

View live Context Therapeutics share price in Dollar and Rupees. Guide to invest in Context Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Context Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Context Therapeutics share price movements

  • Today's Low: $0.84
    Today's High: $0.88

    Day's Volatility :4.0%

  • 52 Weeks Low: $0.77
    52 Weeks High: $2.75

    52 Weeks Volatility :72.0%

Context Therapeutics (CNTX) Returns

PeriodContext Therapeutics IncIndex (Russel 2000)
3 Months
-43.87%
0.0%
6 Months
-63.07%
0.0%
1 Year
-19.81%
0.0%
3 Years
-51.61%
-11.6%

Context Therapeutics (CNTX) Key Statistics

in dollars & INR

Previous Close
$0.8394
Open
$0.85
Today's High
$0.875
Today's Low
$0.84
Market Capitalization
$63.0M
Today's Volume
$32.8K
52 Week High
$2.75
52 Week Low
$0.77
Revenue TTM
$0.0
EBITDA
$-32.5M
Earnings Per Share (EPS)
$-0.89
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-58.98%

How to invest in Context Therapeutics Stock (CNTX) from India?

It is very easy for Indian residents to invest directly in Context Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Context Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Context Therapeutics or CNTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Context Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Context Therapeutics shares which would translate to 1.035 fractional shares of Context Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Context Therapeutics, in just a few clicks!

Returns in Context Therapeutics (CNTX) for Indian investors in Rupees

The Context Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Context Therapeutics investment value today

Current value as on today

₹84,949

Returns

₹15,051

(-15.05%)

Returns from Context Therapeutics Stock

₹20,000 (-20%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Context Therapeutics (CNTX)

19%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Context Therapeutics Stock from India on INDmoney has increased by 19% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Context Therapeutics

  • MPM Oncology Impact Management LP

    19.61%

  • Avidity Partners Management LP

    9.97%

  • Nextech Invest AG

    9.89%

  • Deep Track Capital, LP

    9.89%

  • Blue Owl Capital Holdings LP

    8.48%

  • Great Point Partners LLC

    6.25%

Analyst Recommendation on Context Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Context Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Context Therapeutics Stock (CNTX)

What analysts predicted

Upside of 743.25%

Target:

$7.08

Current:

$0.84

Insights on Context Therapeutics Stock (Ticker Symbol: CNTX)

  • Price Movement

    In the last 3 months, CNTX stock has moved down by -43.9%
  • CNTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 86.3%
  • CNTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 107.5%

Context Therapeutics Technicals Summary

Sell

Neutral

Buy

Context Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Context Therapeutics (CNTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Context Therapeutics Inc logo
-4.21%
-63.07%
-19.81%
-51.61%
-83.49%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Context Therapeutics Inc logo
NA
NA
NA
-0.58
-0.59
-0.37
NA
1.12
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Context Therapeutics Inc logo
Buy
$63.0M
-83.49%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Context Therapeutics

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Organization
Context Therapeutics
Employees
5
CEO
Mr. Martin A. Lehr
Industry
Miscellaneous

Management People of Context Therapeutics

NameTitle
Mr. Martin A. Lehr
Co-Founder, President, CEO & Director
Ms. Jennifer Minai-Azary
CFO & Treasurer
Mr. Alex C. Levit Esq.
Chief Legal Officer & Corporate Secretary
Mr. Christopher Beck M.B.A.
Senior Vice President of Operations
Dr. Claudio Dansky Ullmann M.D.
Chief Medical Officer

Important FAQs about investing in CNTX Stock from India :

What is Context Therapeutics share price today?

Context Therapeutics share price today stands at $0.84, Open: $0.85 ; Previous Close: $0.84 ; High: $0.88 ; Low: $0.84 ; 52 Week High: $2.75 ; 52 Week Low: $0.77.

The stock opens at $0.85, after a previous close of $0.84. The stock reached a daily high of $0.88 and a low of $0.84, with a 52-week high of $2.75 and a 52-week low of $0.77.

Can Indians buy Context Therapeutics shares?

Yes, Indians can invest in the Context Therapeutics (CNTX) from India.

With INDmoney, you can buy Context Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Context Therapeutics at zero transaction cost.

How can I buy Context Therapeutics shares from India?

It is very easy to buy Context Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Context Therapeutics (CNTX) be purchased?

Yes, you can buy fractional shares of Context Therapeutics with INDmoney app.

What are the documents required to start investing in Context Therapeutics stocks?

To start investing in Context Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Context Therapeutics Stock (CNTX)?

Today’s highest price of Context Therapeutics (CNTX) is $0.88.

Today’s lowest price of Context Therapeutics (CNTX) is $0.84.

What is today's market capitalisation of Context Therapeutics?

Today's market capitalisation of Context Therapeutics CNTX is 63.0M

What is the 52 Week High and Low Range of Context Therapeutics Stock (CNTX)?

  • 52 Week High

    $2.75

  • 52 Week Low

    $0.77

What are the historical returns of Context Therapeutics (CNTX)?

  • 1 Month Returns

    -4.21%

  • 3 Months Returns

    -63.07%

  • 1 Year Returns

    -19.81%

  • 5 Years Returns

    -83.49%

Who is the Chief Executive Officer (CEO) of Context Therapeutics ?

Mr. Martin A. Lehr is the current Chief Executive Officer (CEO) of Context Therapeutics.